ArticleJournal of cancer research and clinical oncology2021

Prognostic impact of rapid reduction of involved free light chains in multiple myeloma patients under first-line treatment with Bendamustine, Prednisone, and Bortezomib (BPV).

Tanja Holzhey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.